Literature DB >> 3678218

Serum creatine kinase activity following repeated bouts of isometric exercise with different muscle groups.

J E Graves1, P M Clarkson, P Litchfield, J P Kirwan, J P Norton.   

Abstract

The purpose of this study was to examine the relationship between the muscle mass involved in exercise and post-exercise serum creatine kinase (CK) elevation. Twelve untrained college-aged men completed three isometric exercises: one arm flexion (OAF), two arm flexion (TAF) and one leg knee extension (OLE). These exercises were balanced over subjects and days and separated by two week intervals. Each exercise consisted of 40 maximal isometric concentrations lasting for 10 s with a 20 s rest between contractions. Relative increases in serum CK for OAF, TAF, and OLE were 181 +/- 70% (SD), 222 +/- 69% and 297 +/- 67%, respectively. An ANOVA using a latin square design for analysis of carry over effects showed that these CK increases were not significantly different (p greater than 0.05). However, the increase in serum CK following the first exercise (379 +/- 90%), regardless of what it was (OAF, TAF, or OLE), was significantly greater (p less than 0.05) than those following bouts 2 and 3 (155 +/- 29%; 167 +/- 54%). Regression analysis indicated that post-exercise serum CK elevation was not related to the amount of muscle mass involved in the exercise (r = 0.30, p greater than 0.05) nor to muscle tension developed (r = 0.28, p greater than 0.05). We conclude that post-exercise serum CK elevation is not necessarily related to the muscle mass involved in the exercise. Because each exercise involved the use of different muscle groups, factors outside the exercising muscle may contribute to post-exercise serum enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678218     DOI: 10.1007/bf00424806

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  14 in total

1.  Levels of serum creatine kinase and myoglobin in women after two isometric exercise conditions.

Authors:  J P Kirwan; P M Clarkson; J E Graves; P L Litchfield; W C Byrnes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

2.  Delayed onset muscle soreness following repeated bouts of downhill running.

Authors:  W C Byrnes; P M Clarkson; J S White; S S Hsieh; P N Frykman; R J Maughan
Journal:  J Appl Physiol (1985)       Date:  1985-09

3.  Serum creatine kinase activity following forearm flexion isometric exercise.

Authors:  P M Clarkson; P Litchfield; J Graves; J Kirwan; W C Byrnes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

4.  Serum creatine kinase activity and body composition in males and females.

Authors:  J P Norton; P M Clarkson; J E Graves; P Litchfield; J Kirwan
Journal:  Hum Biol       Date:  1985-12       Impact factor: 0.553

5.  Effects of conditioning on exertional rhabdomyolysis and serum creatine kinase after severe exercise.

Authors:  J H Maxwell; C M Bloor
Journal:  Enzyme       Date:  1981

6.  The relationship of serum creatine kinase, fiber type, and isometric exercise.

Authors:  P M Clarkson; W Kroll; J Graves; W A Record
Journal:  Int J Sports Med       Date:  1982-08       Impact factor: 3.118

7.  Serum creatine kinase as an indicator of local muscular strain in experimental and occupational work.

Authors:  M Hagberg; G Michaelson; A Ortelius
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

Review 8.  Evaluation of myocardial infarction with enzymatic indices.

Authors:  G Ahumada; R Roberts; B E Sobel
Journal:  Prog Cardiovasc Dis       Date:  1976 Mar-Apr       Impact factor: 8.194

9.  Eccentric exercise-induced injury to rat skeletal muscle.

Authors:  R B Armstrong; R W Ogilvie; J A Schwane
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-01

10.  Serum creatine kinase and creatine kinase MB isoenzyme responses of post-infarction patients after a graded exercise test.

Authors:  B Davies; D A Watt; A Daggett
Journal:  Br Heart J       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.